Job Description
The Principal Scientist, Biologics, Cell, and Gene Therapy (BioCGT), plays a critical role within the Analytical Science & Technology team, reporting to the Vertex MS&T function. The successful candidate will act as the subject matter expert (SME) for flow cytometry and cell potency assays. They will lead the analytical method lifecycle management (ALCM) activities for late-stage and commercial applications and provide E2E analytical supports to commercial manufacturing and quality control of Cell and Gene therapy (CGT) products. The Principal Scientist role will collaborate closely with all departments within Vertex and with contract testing sites establishing solid partnerships to ensure compliance with cGMP and Quality Management systems across the global network to effectively deliver our medicines to patients.
Key Responsibilities:
- Lead ALCM projects including late stage and post-marketing approval analytical activities such as method validation and method transfer.
- Be accountable for the success of ALCM projects/activities and ensure on-time deliverables to meet program commitments.
- Be a key contributor to analytical method continuous improvement and lifecycle management.
- Provide analytical supports to the troubleshooting and the investigations during routine manufacturing and quality control operations.
- Be primary SME for analytical testing and method performance executed at CDMOs and contract testing labs, with a focus on flowcytometry methods and potency assays.
- Own ALCM related change controls, deviations, CAPAs and investigations, as needed.
- Represent ASAT in the collaborations with internal Vertex functions including Regulatory CMC, Analytical Development, Process Development, Commercial Manufacturing, Supply Chain, and Quality teams.
- Support regulatory submissions and responses to health agency inquiries in late stage or post-market approval lifecycle.
Knowledge and Skills:
- Demonstrated expertise in biological assay development, validation, transfer, and troubleshooting compliant with GMP operations of Bio-CGT potency methods, including in-vitro cell-based functional/potency methods, in late-stage or commercial environments with a good understanding of GMP operation (required)
- Hands-on experience and in-depth understanding of Flow Cytometry techniques, specifically using BD FACs and/or Miltenyi MACSQuant
- Exceptional writing skills for technical documents, regulatory submissions and responses, investigations, and change controls, with a proven ability to collaborate in a matrix environment (required)
- Advanced knowledge of ALCM regulatory requirements, USP, and ICH guidelines (ICH Q2(R2)).
- Experience in managing contract testing sites (CROs, CMOs) for biologics method development, characterization, technology transfer, and Quality Testing
- Experience of automated analytical instruments is a plus
- Proficient in critical evaluation and interpretation of data, visualization tools, and statistical analysis tools (e.g., JMP)
- Extensive knowledge of Benefit-Risk strategies, problem-solving/root cause analysis for analytical-related issues, and decision-making with the ability to influence colleagues.
- Strong time management and organizational skills with the ability to prioritize multiple projects in a fast-paced environment.
Education and Experience:
- B.S or M.S in Biology, Biochemistry, Cell & Molecular Biology and related fields with a minimum 12 years of experience in the pharmaceutical/biopharmaceutical industry.
- PhD in Biology, Biochemistry and related fields with a minimum of 8 years of industry experience.
Flex Designation:
Hybrid-Eligible Or On-Site Eligible
Flex Eligibility Status:
In this Hybrid-Eligible role, you can choose to be designated as:
1. Hybrid: work remotely up to two days per week; or select
2. On-Site: work five days per week on-site with ad hoc flexibility.
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
Company Information
Vertex is a global biotechnology company that invests in scientific innovation.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at [email protected]
Top Skills
What We Do
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases.
We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development.
Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.